Martina Majo serves as the R&D Director at Synapticure Inc., where she plays a pivotal role in shaping the company’s research strategy and overseeing lab operations. With a robust background in neuroscience, functional genomics, and molecular biology, Martina has been instrumental in advancing Synapticure's initiatives...
Martina Majo serves as the R&D Director at Synapticure Inc., where she plays a pivotal role in shaping the company’s research strategy and overseeing lab operations. With a robust background in neuroscience, functional genomics, and molecular biology, Martina has been instrumental in advancing Synapticure's initiatives in in vitro modeling and biomarker testing. Her expertise in induced pluripotent stem cells (iPSCs) has been particularly valuable, enabling the development of innovative screening platforms that enhance the understanding of neurological disorders and facilitate the discovery of novel therapeutic targets.
Under her leadership, Martina has successfully managed a dynamic research team, fostering a collaborative environment that encourages creativity and scientific rigor. Her strong organizational and management skills have been key in streamlining lab operations, ensuring that projects are executed efficiently while maintaining high standards of quality. Martina's commitment to integrating cutting-edge biochemistry techniques with practical applications in healthcare has positioned Synapticure at the forefront of neuroscience research.
In addition to her technical prowess, Martina actively represents multiple organizations in leadership roles, where she advocates for the advancement of research initiatives and the importance of interdisciplinary collaboration. Her ability to scout emerging trends and technologies in the field allows her to keep Synapticure aligned with industry advancements, ensuring that the company remains a leader in the development of innovative solutions for neurological health. Through her dedication and expertise, Martina Majo continues to drive impactful research that holds the potential to transform patient outcomes in the realm of neuroscience.
